Live Breaking News & Updates on Aurinia Lupkynis

Stay updated with breaking news from Aurinia lupkynis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

In a Push to Limit Use of Glucocorticoids, US and EU5 Rheumatologists are Increasingly Turning ...

Exton, Pennsylvania, Oct. 04, 2023 (GLOBE NEWSWIRE) Prior to the initial approval of Benlysta in 2011, systemic lupus erythematosus (SLE) patients and prescribers had limited options for the management ....

United States , Aurinia Lupkynis , Astrazeneca Saphnelo , Maxine Yarnall Spherix , European Union , Spherix Network , Global Insights , Patient Chart Dynamix , Realworld Dynamix , Chart Dynamix , Spherix Global Insights , Spherix Global Insight , Yarnall Spherix Global Insights , Systemic Lupus Erythematosus , Lupus Nephritis , Kidney Disease , Skin Conditions ,

New Research on Emerging Cutaneous Lupus Erythematosus (CLE) Market Reveals Vast Potential for Pipeline Agents, According to Spherix Global Insights

/PRNewswire/ According to the Lupus Foundation of America, approximately two-thirds of people with the autoimmune condition systemic lupus erythematosus. ....

United States , Scott Upham , Aurinia Lupkynis , Bristol Myer Squibb Sotyktu , Bryan Rex , Astrazeneca Saphnelo , Corporate Communications , Spherix Network , Lupus Foundation Of America , Lupus Foundation , Global Insight , Market Dynamix , Cutaneous Lupus Erythematosus , Bristol Myer Squibb , Global Insights , Spherix Global Insights , Insights Director , Spherix Global Insight ,

Major Shifts in Management of Patients with Lupus Nephritis Spurred by Availability of Aurinia Pharmaceutical's Lupkynis and GSK's Benlysta, According to Spherix Global Insights

/PRNewswire/ With the approvals of GlaxoSmithKline s Benlysta (belimumab) in lupus nephritis (LN) at the end of 2020 and Aurinia s Lupkynis (voclosporin) at. ....

Novarti Cosentyx , Astrazeneca Saphnelo , Glaxosmithkline Benlysta , Scott Upham , Roche Genentech Gazyva , Aurinia Lupkynis , Bryan Rex , Janssen Tremfya , Corporate Communications , Spherix Network , Spherix Global Insights , Global Insights , Realworld Dynamix , Lupus Nephritis , Vera Therapeutic , World Dynamix , Global Insights Contacts , Rheumatology Insights ,

European Lupus Market Coverage Highlights Pipeline Perceptions and Country Differences in Patient Management, Spherix Reports

/PRNewswire/ Rheumatologists have long struggled to effectively treat patients with systemic lupus erythematosus (SLE) given the wide heterogeneity of the. ....

United Kingdom , Astrazeneca Saphnelo , Aurinia Lupkynis , Glaxosmithkline Benlysta , Bryan Rex , Roche Gazyva , National Institute For Health , Bristol Myers Squibb , Global Insights , Market Dynamix , Realworld Dynamix , National Institute , Care Excellence , Participating United Kingdom , World Dynamix , Rheumatology Insights , Spherix Global Insights ,

Spherix Research Reveals Rheumatologists Taking the Lead Over Nephrologists in Both BENLYSTA (GlaxoSmithKline) and LUPKYNIS (Aurinia) Patient Initiations in Lupus Nephritis

/PRNewswire/ With the approvals of GlaxoSmithKline s Benlysta in lupus nephritis (LN) at the end of 2020 and Aurinia s Lupkynis at the beginning of 2021,. ....

Novartis Cosentyx , Roche Genentech Gazyva , Chemocentryx Tavneos , Maxine Yarnall , Aurinia Lupkynis , Glaxosmithkline Benlysta , Janssen Tremfya , Our Services , Launch Dynamix , Global Insights , Rheumatology Franchise , Spherix Global Insights ,